Predicting glucose sensor behavior in blood using transport modeling: Relative impacts of protein biofouling and cellular metabolic efects

Journal of Diabetes Science and Technology

Volumn 7, Issue 6, 2013, Pages 1547-1560

  Novak, Matthew T ^a   Yuan, Fan ^a   Reichert, William M ^a  

^a Duke University   (United States)

Author keywords

Biocompatibility; Biomaterials; Biosensors; Modeling

Indexed keywords

GLUCOSE; PHOSPHATE BUFFERED SALINE;

ARTICLE; BIOFOULING; BLOOD COMPONENT; CELL VOLUME; COMPUTER SIMULATION; CONTROLLED STUDY; DIFFUSION COEFFICIENT; ERYTHROCYTE; EX VIVO STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; GLUCOSE METABOLISM; GLUCOSE SENSOR; GLUCOSE TRANSPORT; HUMAN; INFLAMMATORY CELL; MACROPHAGE; MICHAELIS CONSTANT; MICHAELIS MENTEN KINETICS; POROSITY; PROTEIN AGGREGATION; PROTEIN BIOFOULING; REPRODUCIBILITY; SCANNING ELECTRON MICROSCOPY; TEST STRIP; THROMBOCYTE POOR PLASMA;

BIOFOULING; BIOLOGICAL TRANSPORT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; COMPUTER SIMULATION; GLUCOSE; HUMANS; INFLAMMATION; LEUKOCYTES; MODELS, BIOLOGICAL; PREDICTIVE VALUE OF TESTS; PROSTHESES AND IMPLANTS; SUBCUTANEOUS TISSUE;

EID: 84893682836     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681300700615     Document Type: Article

References (29)

1. Koschinsky T, Heinemann L. Sensors for glucose monitoring: technical and clinical aspects. Diabetes Metab Res Rev. 2001;17(2):113-23.
2. Novak MT, Yuan F, Reichert WM. Modeling the relative impact of capsular tissue effects on implanted glucose sensor time lag and signal attenuation. Anal Bioanal Chem. 2010;398(4):1695-705.
3. Ginsberg BH. The FDA Panel advises approval of the first continuous glucose sensor. Diabetes Technol Ther. 1999;1(2):203-4.
4. Mastrototaro JJ. The MiniMed continuous glucose monitoring system. Diabetes Technol Ther. 2000;2 Suppl 1:S13-8.
5. Garg SK. The future of continuous glucose monitoring. Diabetes Technol Ther. 2009;11 Suppl 1:S1-3.
6. Skyler JS. Continuous glucose monitoring: an overview of its development. Diabetes Technol Ther. 2009;11 Suppl 1:S5-10.
7. Sharkawy AA, Klitzman B, Truskey GA, Reichert WM. Engineering the tissue which encapsulates subcutaneous implants. II. Plasma-tissue exchange properties. J Biomed Mater Res. 1998;40(4):586-97.
8. Wisniewski N, Klitzman B, Miller B, Reichert WM. Decreased analyte transport through implanted membranes: differentiation of biofouling from tissue efects. J Biomed Mater Res. 2001;57(4):513-21.
9. Sharkawy AA, Klitzman B, Truskey GA, Reichert WM. Engineering the tissue which encapsulates subcutaneous implants. I. Difusion properties. J Biomed Mater Res. 1997;37(3):401-12.
10. Prichard HL, Schroeder T, Reichert WM, Klitzman B. Bioluminescence imaging of glucose in tissue surrounding polyurethane and glucose sensor implants. J Diabetes Sci Technol. 2010;4(5):1055-62.
11. Klueh U, Liu Z, Ouyang T, Cho B, Feldman B, Henning TP, Kreutzer D. Blood-induced interference of glucose sensor function in vitro: implications for in vivo sensor function. J Diabetes Sci Technol. 2007;1(6):842-9.
12. Klueh U, Liu Z, Feldman B, Henning TP, Cho B, Ouyang T, Kreutzer D. Metabolic biofouling of glucose sensors in vivo: role of tissue microhemorrhages. J Diabetes Sci Technol. 2011;5(3):583-95.
13. Hirsh J, Anand SS, Halperin JL, Fuster V; American Heart Association. Guide to anticoagulant therapy: heparin : a statement for healthcare professionals from the American Heart Association. Circulation. 2001;103(24):2994-3018.
14. Weibrich G, Kleis WK, Hafner G, Hitzler WE, Wagner W. Comparison of platelet, leukocyte, and growth factor levels in point-of-care plateletenriched plasma, prepared using a modified Curasan kit, with preparations received from a local blood bank. Clin Oral Implants Res. 2003;14(3):357-62.
15. Yang H, Wang D, Engelstad K, Bagay L, Wei Y, Rotstein M, Aggarwal V, Levy B, Ma L, Chung WK, De Vivo DC. Glut1 deficiency syndrome and erythrocyte glucose uptake assay. Ann Neurol. 2011;70(6):996-1005.
16. Ahmed N, Kansara M, Berridge MV. Acute regulation of glucose transport in a monocyte-macrophage cell line: Glut-3 affinity for glucose is enhanced during the respiratory burst. Biochem J. 1997;327 (Pt 2):369-75.
17. Nefesh I, Bauskin AR, Alkalay I, Golembo M, Ben-Neriah Y. IL-3 facilitates lymphocyte hexose transport by enhancing the intrinsic activity of the transport system. Int Immunol. 1991;3(8):827-31.
18. Tan AS, Ahmed N, Berridge MV. Acute regulation of glucose transport after activation of human peripheral blood neutrophils by phorbol myristate acetate, fMLP, and granulocyte-macrophage colony-stimulating factor. Blood. 1998;91(2):649-55.
19. Nurdin N, François P, Mugnier Y, Krumeich J, Moret M, Aronsson BO, Descouts P. Haemocompatibility evaluation of DLC- and SiC-coated surfaces. Eur Cell Mater. 2003;5:17-28.
20. Turgeon ML. Clinical hematology: theory and procedures. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2005.
21. Carruthers A, Melchior DL. Transport of alpha- and beta-D-glucose by the intact human red cell. Biochemistry. 1985;24(15):4244-50.
22. Carruthers A. Facilitated diffusion of glucose. Physiol Rev. 1990;70(4):1135-76.
23. Cloherty EK, Levine KB, Carruthers A. The red blood cell glucose transporter presents multiple, nucleotide-sensitive sugar exit sites. Biochemistry. 2001;40(51):15549-61.
24. Rist RJ, Jones GE, Naftalin RJ. Effects of macrophage colony-stimulating factor and phorbol myristate acetate on 2-D-deoxyglucose transport and superoxide production in rat peritoneal macrophages. Biochem J. 1991;278 (Pt 1):119-28.
25. Kiyotaki C, Peisach J, Bloom BR. Oxygen metabolism in cloned macrophage cell lines: glucose dependence of superoxide production, metabolic and spectral analysis. J Immunol. 1984;132(2):857-66.
26. Leypoldt JK, Gough DA. Model of a two-substrate enzyme electrode for glucose. Anal Chem. 1984;56(14):2896-904.
27. Gough DA, Lucisano JY, Tse PH. Two-dimensional enzyme electrode sensor for glucose. Anal Chem. 1985;57(12):2351-7.
28. Gough DA, Kumosa LS, Routh TL, Lin JT, Lucisano JY. Function of an Implanted Tissue Glucose Sensor for More than 1 Year in Animals. Sci Transl Med. 2010;2(42):42ra53.
29. Babior BM. Oxygen-dependent microbial killing by phagocytes (first of two parts). N Engl J Med. 1978;298(12):659-68.